Vimarsana
Biggest News Aggregation in the World

Page 45 - Technology Analytics Solutions News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Technology Analytics Solutions. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Technology Analytics Solutions Today - Breaking & Trending Today

AtonRa Partners Sells 313 Shares of IQVIA Holdings Inc. (NYSE:IQV) - Vimarsana News

AtonRa Partners Sells 313 Shares of IQVIA Holdings Inc. (NYSE:IQV)

AtonRa Partners lessened its position in shares of IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 9.4% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,017 shares of the medical research company’s stock after selling 313 shares during the […]

IQVIA Holdings Inc. (NYSE:IQV) Shares Acquired by Premier Fund Managers Ltd - Vimarsana News

IQVIA Holdings Inc. (NYSE:IQV) Shares Acquired by Premier Fund Managers Ltd

Premier Fund Managers Ltd grew its stake in IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 9.5% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 230,000 shares of the medical research company’s stock after acquiring an additional 20,000 shares during the quarter. IQVIA […]

Morgan Stanley Raises IQVIA (NYSE:IQV) Price Target to $240.00 - Vimarsana News

Morgan Stanley Raises IQVIA (NYSE:IQV) Price Target to $240.00

IQVIA (NYSE:IQV – Get Free Report) had its target price hoisted by equities researchers at Morgan Stanley from $220.00 to $240.00 in a research note issued to investors on Wednesday, Benzinga reports. The brokerage currently has an “overweight” rating on the medical research company’s stock. Morgan Stanley’s price target indicates a potential upside of 9.54% […]

IQVIA (NYSE:IQV) PT Raised to $225.00 at Citigroup - Vimarsana News

IQVIA (NYSE:IQV) PT Raised to $225.00 at Citigroup

IQVIA (NYSE:IQV – Get Free Report) had its price objective lifted by research analysts at Citigroup from $200.00 to $225.00 in a research note issued to investors on Wednesday, Benzinga reports. The firm presently has a “neutral” rating on the medical research company’s stock. Citigroup’s price objective suggests a potential upside of 2.70% from the […]

Source: wkrb13.com
IQVIA Holdings Inc. (NYSE:IQV) Shares Sold by KBC Group NV - Vimarsana News

IQVIA Holdings Inc. (NYSE:IQV) Shares Sold by KBC Group NV

KBC Group NV trimmed its position in IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 34.6% in the first quarter, HoldingsChannel.com reports. The firm owned 109,285 shares of the medical research company’s stock after selling 57,729 shares during the quarter. KBC Group NV’s holdings in IQVIA were worth $21,736,000 at the end of the most […]